Inventor · disambiguated record
Lloyd Jeffs
Also filed as: JEFFS LLOYD · JEFFS LLOYD B · JEFFS LLOYD BRIAN
18 granted patents·18 pending applications·2,118 citations·filing 2003–2024
97Inventor score
Files withPROTIVA BIOTHERAPEUTICS INC15ARBUTUS BIOPHARMA CORP14MACLACHLAN IAN3YAWORSKI EDWARD2ALNYLAM PHARMACEUTICALS INC1
Top patents by PatentIndex Score
36 records- 0198US11718852B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Aug 8, 2023·5 cites·32 claims
- 0298US11141378B2Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2021·Granted Oct 12, 2021·42 cites·30 claims
- 0398US9518272B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·116 cites·22 claims
- 0498US9504651B2Lipid compositions for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·144 cites·14 claims
- 0598US9492386B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Nov 15, 2016·72 cites·20 claims
- 0698US9404127B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·131 cites·22 claims
- 0798US9364435B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·194 cites·20 claims
- 0898US8822668B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Sep 2, 2014·99 cites·23 claims
- 0998US8492359B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2011·Granted Jul 23, 2013·109 cites·21 claims
- 1098US8058069B2Lipid formulations for nucleic acid deliveryYAWORSKI EDWARD·Filed 2009·Granted Nov 15, 2011·585 cites·22 claims
- 1198US7901708B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2003·Granted Mar 8, 2011·344 cites·22 claims
- 1297US12129467B2Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Granted Oct 29, 2024·2 cites·24 claims
- 1397US11318098B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted May 3, 2022·3 cites·30 claims
- 1497US11298320B2Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Granted Apr 12, 2022·3 cites·30 claims
- 1597US9006417B2Non-liposomal systems for nucleic acid deliveryYAWORSKI ED·Filed 2011·Granted Apr 14, 2015·55 cites·24 claims
- 1696US8329070B2Liposomal apparatus and manufacturing methodMACLACHLAN IAN·Filed 2010·Granted Dec 11, 2012·158 cites·13 claims
- 1795US8598333B2SiRNA silencing of genes expressed in cancerMACLACHLAN IAN·Filed 2007·Granted Dec 3, 2013·27 cites·8 claims
- 1893US9005654B2Systems and methods for manufacturing liposomesMACLACHLAN IAN·Filed 2006·Granted Apr 14, 2015·29 cites·16 claims
- 1991US2025034571A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 2089US2024035030A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 2188US2023372245A1Lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2023·Application pending·0 cites
- 2279US2020268664A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 2378US2021267891A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2021·Application pending·0 cites
- 2478US2020113832A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2019·Application pending·0 cites
- 2577US2021220274A1Novel lipid formulations for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2020·Application pending·0 cites
- 2674US2019167586A1Liposomal apparatus and manufacturing methodsARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 2772US2019032051A1Non-liposomal systems for nucleic acid deliveryARBUTUS BIOPHARMA CORP·Filed 2018·Application pending·0 cites
- 2869US2017258719A1Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2968US2018092848A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3067US2017260523A1Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3167US2018085312A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3263US2017042814A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3357US2014161894A1Sirna silencing of genes expressed in cancerALNYLAM PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3451US2006134189A1siRNA silencing of apolipoprotein BPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 3548US2011189300A1siRNA SILENCING OF APOLIPOPROTEIN BPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3645US2006051405A1Compositions for the delivery of therapeutic agents and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lloyd Jeffs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →